Regeneron Pharmaceuticals, Inc.
ANTI-TMPRSS2 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS

Last updated:

Abstract:

The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to TMPRSS2 and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infections or influenza virus infections).

Status:
Application
Type:

Utility

Filling date:

9 Feb 2021

Issue date:

12 Aug 2021